Liquid chromatographic-mass spectrometric method for the determination of fluoxetine and norfluoxetine in human plasma: Application to clinical study

Farmaco

Volumn 60, Issue 4, 2005, Pages 345-349

  Djordjevic, S ^a   Kovacevic, I ^b,c   Miljkovic, B ^b   Vuksanovic, J ^a   Pokrajac, M ^b  

^a UNIVERSITY OF DEFENCE   (Serbia)

^b Institute of Bromatology   (Yugoslavia)

^c Institute of Pharmacy of Serbia   (Yugoslavia)

Author keywords

Fluoxetine; High performance liquid chromatography; Mass spectrometry; Norfluoxetine; Pharmacokinetics

Indexed keywords

ACETIC ACID ETHYL ESTER; FLUMAZENIL; FLUOXETINE; NORFLUOXETINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ELUTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MASS SPECTROMETRY; PARKINSON DISEASE; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; STANDARD; VALIDATION PROCESS;

EID: 17444431165     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.farmac.2005.01.002     Document Type: Article

References (27)

1. L. Yeel, S. Wong, and V. Skrinska Chiral high-performance liquid chromatographic analysis of fluoxetine and norfluoxetine in rabbit plasma, urine, and vitreous humor using an acetylated b-cyclodextrin column J. Anal. Toxicol. 24 2000 651 655
2. The Extra Pharmacopoeia Martindale, 31st ed 1995 Pharmaceutical Press London
3. P. Benfield, R.C. Hee, and S.P. Lewis Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness Drugs 32 1986 481 508
4. B. Saletu, and T. Grunberger Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analysis J. Clin. Psychiatry 46 1985 45 52
5. C.B. Eap, and P. Baumann Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients J. Chromatogr. B. 686 1996 51 63
6. J.H. Nichols, J.R. Charison, and G.M. Lawson Automated HPLC assay of fluoxetine and norfluoxetine in serum Clin. Chem. 40 1994 1312 1316
7. V. Dixit, H. Nguyen, and V.M. Dixit Solid-phase extraction of fluoxetine and norfluoxetine from serum with gas-chromatography-electron-capture detection J. Chromatogr. Biomed. Appl. 563 1991 379 384
8. G. Misztal, R. Skibinski, and M. Olajossy Application of HPLC method for the determination of racemic fluoxetine and norfluoxetine in human plasma Chem. Anal. 47 2002 229
9. R.N. Pan, T.H. Chen, C. Huand, and C.H. Hsiong Pharmacokinetics and bioequivalent study of generic fluoxetine capsules preparation J. Food and Drug Anal. 1 2002 13 17
10. R.N. Gupta An improved solid phase extraction procedure for the determination of antidepressants in serum by column liquid chromatography J. Liq. Chromatogr. 16 1993 2751 2765
11. A. El Yazigi, and D.A. Raines Concurrent liquid chromatographic measurement of fluoxetine, amitriptyline, imipramine, and their active metabolites norfluoxetine, notrtriptyline, and desipramine in plasma Ther. Drug Monit. 15 1993 305 309
12. 8 column and ultraviolet detection Clin. Chem. 39 1993 1749 1750
13. J.H. Nichols, J.R. Charlson, and G.M. Lawson Automated HPLC assay of fluoxetine and norfluoxetine in serum Clin. Chem. 40 1994 1312 1316
14. A. Kaddoumi, M.N. Nakashima, and K. Nakashima Fluorometric determination of dl-fenfluramine, dl-norfenfluramine and phentermine in plasma by achiral and chiral high-performance liquid chromatography J. Chromatogr. B Biomed. Sci. Appl. 763 2001 79 90
15. R.F. Suckow, M.F. Zhang, and T.B. Cooper Sensitive and selective liquid-chromatographics assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization Clin. Chem. 38 1992 1756 1761
16. A. Peyton, R. Carpenter, and K. Rutkowski The stereospecific determination of fluoxetine and norfluoxetine enantiomers in human plasma by high-pressure liquid chromatography (HPLC) with fluorescence detection Pharm. Res. 8 1991 1528 1532
17. R.S. Addison, M.E. Franklin, and W.D. Hooper Sensitive, high-throughput chromatographic-mass spectrometric assay for fluoxetine and norfluoxetine in human plasma and its application to pharmacokinetic studies J. Chromatogr. B 716 1998 153 160
18. C.B. Eap, N. Gailard, K. Powel, and P. Bauman Simultaneous determination of plasma levels of fluvoxamine and of the enantiomers of fluoxetine and norfluoxetine by gas chromatograpy-mass spectrometry J. Chromatogr. B Biomed. Appl. 682 1996 265 272
19. J.J. Berzas Nevado, M.J. Villasenor Llerena, A.M. Contento Salcedo, and E. Aguas Nuevo Determination of fluoxetine, fluvoxamine, and clomipramine in pharmaceutical formulations by capillary gas chromatography J. Chro. Sci. 5 2000 200 206
20. J.F. Nash, R.J. Bopp, R.H. Carmichael, K.Z. Farid, and L. Lemberger Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron-capture detection Clin. Chem. 28 1982 2100 2102
21. R.J. Lantz, K.Z. Farid, J. Koons, J.B. Tenbarge, and R.J. Bopp Determination of fluoxetine and norfluoxetine in human plasma by capillary gas chromatography with electron capture detection J. Chromatogr. Biomed. Appl. 614 1993 175 179
22. G.A. Torok Both, G.B. Backer, R.T. Couts, K.F. McKennaF, and L.J. Aspeslet Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection J. Chromatogr. Biomed. Appl 579 1992 99 106
23. P. Fontanille, N. Jourdil, C. Villier, and G. Bessard Direct analysis of fluoxetine and norfluoxetine in plasma by gas chromatography with nitrogen-phosphorus detection J. Chromatogr. B. 692 1997 337 343
24. G. Tournel, N. Houdret, V. Hedouin, M. Deveaux, D. Gosset, and M. Lhermitte High-performance liquid chromatographic method to screen and quantitate seven selective serotonin reuptake inhibitors in human plasma J. Chromatogr. B. 761 2001 147 158
25. A. Llerena, P. Dorado, R. Berecz, A. Gonzales, M.J. Norberto, A. De la Rubia, and M. Caceres Determination of fluoxetine and norfluoxetine in human plasma by high-performance liquid chromatography with ultraviolet detection in psychiatric patients J. Chromatogr. B. 783 2003 25 31
26. P.J. Orsulak, J.T. Keney, J.R. Debus, G. Crowley, and P.D. Wittman Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum reversed-phase HPLC, with ultraviolet detection Clin. Chem. 34 1988 1875 1878
27. G.B. Baker, J. Fang, S. Sinha, and R.T. Coutts Metabolic drug interactions with selective serotonin reuptake inhibitor (SSRI) Antidepressants, Neurosci. Biobehav. Rev. 22 1998 325 333